Medicare drug price caps remain in place despite Trump executive order | Fact check
An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...
Florida Seeks Personal Prescription Data From Drug Middlemen
Florida insurance regulators have asked companies to hand over extensive amounts of data on people’s pharmacy claims, ...
Benefits Pro16h
Killing the PBMs won't save drug costs, economist says
Some House bills would prohibit PBMs from collecting certain kinds of compensation, such as fees tied to the size of the drug ...
Business Wire17h
SmithRx Introduces Stelara Biosimilars to Its Autoimmune Program, Helping Clients Save a Projected $14.5M in Prescription Drug Costs
SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), today announced a major expansion to its Connect 360 Autoimmune Prog ...
Who is eligible for both Medicare and Medicaid in California? Beneficiaries with dual eligibility
In California, some individuals qualify for both Medicare and Medi-Cal, a status known as dual eligibility or "Medi-Medi." ...
Benefits Pro19h
$35.8B: Medicare diabetes drug costs skyrocket
Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit ...
The Vicksburg Post19h
Independent pharmacists urge legislators to pass pharmacy benefit manager reform bill
This article was written by Gwen Dilworth of Mississippi Today A group of independent pharmacists from across Mississippi ...
Opinion
This bill was supposed to help OK patients. It fattens hospital wallets instead. | Opinion
The proposed Oklahoma law would send more money to hospitals and chain pharmacies, not help Oklahomans, especially in rural areas.